Miniatura

Fitxers

677162.pdf (400.81 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2017-03-15

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/120610

Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1002/ijc.30560

Resum

Endometrial cancer risk prediction models including lifestyle, anthropometric and reproductive factors have limited discrimination. Adding biomarker data to these models may improve predictive capacity; to our knowledge, this has not been investigated for endometrial cancer. Using a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, we investigated the improvement in discrimination gained by adding serum biomarker concentrations to risk estimates derived from an existing risk prediction model based on epidemiologic factors. Serum concentrations of sex steroid hormones, metabolic markers, growth factors, adipokines and cytokines were evaluated in a step-wise backward selection process; biomarkers were retained at p < 0.157 indicating improvement in the Akaike information criterion (AIC). Improvement in discrimination was assessed using the C-statistic for all biomarkers alone, and change in C-statistic from addition of biomarkers to preexisting absolute risk estimates. We used internal validation with bootstrapping (1000-fold) to adjust for over-fitting. Adiponectin, estrone, interleukin-1 receptor antagonist, tumor necrosis factor-alpha and triglycerides were select-ed into the model. After accounting for over-fitting, discrimination was improved by 2.0 percentage points when all evaluated biomarkers were included and 1.7 percentage points in the model including the selected biomarkers. Models including etiologic markers on independent pathways and genetic markers may further improve discrimination.

Descripció

Matèries

Càncer d'endometri, Marcadors bioquímics, Nutrició, Sèrum

Matèries (anglès)

Endometrial cancer, Biochemical markers, Nutrition, Serum

Citació

Col·leccions

Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

FORTNER, Renée t., HÜSING, Anika, KÜHN, Tilman, KONAR, Meric, OVERVAD, Kim, TJØNNELAND, Anne, HANSEN, Louise, BOUTRON-RUAULT, Marie-christine, SEVERI, Gianluca, FOURNIER, Agnès, BOEING, Heiner, TRICHOPOULOU, Antonia, BENETOU, Vassiliki, ORFANOS, Philippos, MASALA, Giovanna, AGNOLI, Claudia, MATTIELLO, Amalia, TUMINO, Rosario, SACERDOTE, Carlotta, BUENO DE MESQUITA, H. bas, PEETERS, Petra h. m., WEIDERPASS, Elisabete, GRAM, Inger t., GAVRILYUK, Oxana, QUIRÓS, José ramón, HUERTA CASTAÑO, José maría, ARDANAZ, Eva, LARRAÑAGA, Nerea, LUJÁN BARROSO, Leila, SÁNCHEZ CANTALEJO, Emilio, TUNÅ BUTT, Salma, BORGQUIST, Signe, IDAHL, Annika, LUNDIN, Eva, KHAW, Kay-tee, ALLEN, Naomi e., RINALDI, Sabina, DOSSUS, Laure, GUNTER, Marc j., MERRITT, Melissa a.. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort. _International Journal of Cancer_. 2017. Vol. 140, núm. 6, pàgs. 1317-1323. [consulta: 10 de desembre de 2025]. ISSN: 0020-7136. [Disponible a: https://hdl.handle.net/2445/120610]

Exportar metadades

JSON - METS

Compartir registre